Adults 21 to 55, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Motion PerceptionPrimary· During the rotation of the chair, approximately 1 hr
Motion Perception verbal report using a visual analog scale (1-100) will be recorded during the rotation of the chair (1=feeling no motion perception; 100=feeling the maximum motion perception)
No GVS
Group
Value
95% CI
Galvanic Vestibular Stimulation
55.3
± 32.2
GVS Entire Session
Group
Value
95% CI
Galvanic Vestibular Stimulation
49.7
± 34.0
GVS from Mid-Session
Group
Value
95% CI
Galvanic Vestibular Stimulation
50.1
± 33.6
Motion Sickness QuestionnaireSecondary· During the rotation of the chair, approximately 1 hr
subjective experiences of motion sickness in a scale of 0-10 (0=not at all; 10=most severe)
No GVS
Group
Value
95% CI
Galvanic Vestibular Stimulation
3.0
± 2.9
GVS Entire Session
Group
Value
95% CI
Galvanic Vestibular Stimulation
3.2
± 3.2
GVS from Mid-Session
Group
Value
95% CI
Galvanic Vestibular Stimulation
3.4
± 3.1
Sponsor's own description
The purpose of this study is evaluate the effect of timing and magnitude on the administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the effect of Galvanic Vestibular Stimulation (GVR) amplitude on functional fitness task performance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06123949 — The Effect of Galvanic Stimulation on vHIT and VEMP Tests
· NA
· completed
NCT03831594 — Combining Physical Therapy With Vestibular Stimulation to Improve Postural Stability in Pusher's Syndrome
· NA
· withdrawn
NCT02979314 — The Influence of GVS on Mental Transformation
· NA
· completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
NCT06707207 — Predicting Future Errors During Skill Performance
· recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
· Phase 1
· recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
· NA
· recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects
· NA
· recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity
· Phase 1, PHASE2
· recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
· NA
· not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
· not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance,
· NA
· not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)
· NA
· recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04859868.